HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A randomised trial of vitamin D in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.

Abstract
Vitamin D has been demonstrated to have an immunomodulatory role in cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Herein, we evaluate supplemental vitamin D in acute-stage ABPA complicating asthma. Thirty subjects were randomised to receive either prednisolone (n = 15, control) or prednisolone and oral vitamin D (n = 15, intervention arm). Serum vitamin D levels were significantly higher in the intervention versus the control arm, following therapy. The mean decline in total IgE at 2 months (primary outcome) was 10% higher in the intervention arm than the control arm; however, this was not statistically significant (48.6% vs 38.1%, P = 0.27). The percentage decline in total IgE after 4 and 6 months of randomisation was also similar in the two arms. There was no difference in asthma exacerbations (0 vs 2, intervention vs control; P = 0.16). No ABPA exacerbation occurred in either arm. The other outcomes including the Th2 (IL-4, IL-6 and IL-10) and Th17 (IL-17) cytokine levels were similar in the two groups. None of the participants experienced hypervitaminosis D. There was no significant improvement in the clinical or immunological outcomes following vitamin D supplementation. A larger trial is required to ascertain the role of vitamin D in ABPA complicating asthma [Clinicaltrials.gov: NCT03133299].
AuthorsManjunath Havalappa Dodamani, Valliappan Muthu, Reetu Thakur, Arnab Pal, Inderpaul Singh Sehgal, Sahajal Dhooria, Ashutosh N Aggarwal, Mandeep Garg, Arunaloke Chakrabarti, Ritesh Agarwal
JournalMycoses (Mycoses) Vol. 62 Issue 4 Pg. 320-327 (Apr 2019) ISSN: 1439-0507 [Electronic] Germany
PMID30561849 (Publication Type: Journal Article, Randomized Controlled Trial)
Copyright© 2018 Blackwell Verlag GmbH.
Chemical References
  • Cytokines
  • Immunologic Factors
  • Vitamin D
  • Immunoglobulin E
  • Prednisolone
Topics
  • Administration, Oral
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Aspergillosis, Allergic Bronchopulmonary (complications, drug therapy, pathology)
  • Asthma (complications, drug therapy, pathology)
  • Child
  • Cytokines (blood)
  • Female
  • Humans
  • Immunoglobulin E (blood)
  • Immunologic Factors (administration & dosage)
  • Male
  • Middle Aged
  • Prednisolone (administration & dosage)
  • Prospective Studies
  • Treatment Outcome
  • Vitamin D (administration & dosage)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: